These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33859934)

  • 21. Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database.
    Uhlig J; Cecchini M; Sheth A; Stein S; Lacy J; Kim HS
    J Natl Compr Canc Netw; 2021 Feb; 19(3):307-318. PubMed ID: 33530058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer.
    Mohan HM; Ryan E; Balasubramanian I; Kennelly R; Geraghty R; Sclafani F; Fennelly D; McDermott R; Ryan EJ; O'Donoghue D; Hyland JM; Martin ST; O'Connell PR; Gibbons D; Winter D; Sheahan K
    Eur J Surg Oncol; 2016 Nov; 42(11):1680-1686. PubMed ID: 27370895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE).
    Dijkstra M; Nieuwenhuizen S; Puijk RS; Timmer FEF; Geboers B; Schouten EAC; Opperman J; Scheffer HJ; de Vries JJJ; Versteeg KS; Lissenberg-Witte BI; van den Tol MP; Meijerink MR
    Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer.
    Khalil L; Gao X; Switchenko JM; Alese OB; Akce M; Wu C; Diab M; El-Rayes BF; Shaib WL
    Oncologist; 2022 Sep; 27(9):740-750. PubMed ID: 35648074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microsatellite Instability as a Prognostic Factor in Stage II Colon Cancer Patients, a Meta-Analysis of Published Literature.
    Gkekas I; Novotny J; Pecen L; Strigård K; Palmqvist R; Gunnarsson U
    Anticancer Res; 2017 Dec; 37(12):6563-6574. PubMed ID: 29187431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
    de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
    Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value of the Microsatellite Instability Status in Patients With Stage II/III Rectal Cancer Following Upfront Surgery.
    Oh CR; Kim JE; Kang J; Kim SY; Kim KP; Hong YS; Lim SB; Yu CS; Kim JC; Kim J; Jang SJ; Kim TW
    Clin Colorectal Cancer; 2018 Dec; 17(4):e679-e685. PubMed ID: 30077598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
    Chouhan H; Sammour T; Thomas ML; Moore JW
    J Surg Oncol; 2018 Dec; 118(8):1311-1317. PubMed ID: 30399198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic effect of sidedness in early stage versus advanced colon cancer.
    Kennecke HF; Yin Y; Davies JM; Speers CH; Cheung WY; Lee-Ying R
    Health Sci Rep; 2018 Aug; 1(8):e54. PubMed ID: 30623090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of KRAS mutation, microsatellite instability, and tumor laterality on the prognosis of nonmetastatic colon cancer.
    Tran CG; Goffredo P; Mott SL; Hart A; You YN; Vauthey JN; Weigel RJ; Hassan I
    Surgery; 2022 Mar; 171(3):657-665. PubMed ID: 34865865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsatellite instability did not predict individual survival in sporadic stage II and III rectal cancer patients.
    Meng WJ; Sun XF; Tian C; Wang L; Yu YY; Zhou B; Gu J; Xia QJ; Li Y; Wang R; Zheng XL; Zhou ZG
    Oncology; 2007; 72(1-2):82-8. PubMed ID: 18004081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of microsatellite instability status and sidedness of the primary tumor on the effect of bevacizumab-containing chemotherapy in patients with metastatic colorectal cancer.
    Kim ST; Kim HK; Lee J; Park SH; Lim HY; Park YS; Kang WK; Park JO
    J Cancer; 2018; 9(10):1791-1796. PubMed ID: 29805705
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical, pathological, and adjuvant chemotherapy use differences among microsatellite unstable and microsatellite stable colon cancers.
    Jafry BH; Buhaya MH; Milsap A; Jones AL; Goksu SY; Verma N; Brown TJ; Hughes A; Nair R; Sanford N; Su J; Huang E; Kazmi SMA
    J Natl Cancer Cent; 2024 Jun; 4(2):169-175. PubMed ID: 39282583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Oncologic Outcomes Between Incomplete Obstructive Colon Cancer and Non-Obstructive Colon Cancer by Tumor Location.
    Lim JH; Lee WY; Yun SH; Kim HC; Cho YB; Huh JW; Park YA; Shin JK
    Front Oncol; 2022; 12():914299. PubMed ID: 35734589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The side of the primary tumor affects overall survival in colon adenocarcinoma: an analysis of the national cancer database.
    Turner MC; Becerra D; Sun Z; Watson J; Leung K; Migaly J; Mantyh CR; Blazer DG
    Tech Coloproctol; 2019 Jun; 23(6):537-544. PubMed ID: 31190234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a 55-gene classifier as a prognostic biomarker for adjuvant chemotherapy in stage III colon cancer patients.
    Oki E; Shinto E; Shimokawa M; Yamaguchi S; Ishiguro M; Hasegawa S; Takii Y; Ishida H; Kusumoto T; Morita M; Tomita N; Shiozawa M; Tanaka M; Ozawa H; Hashiguchi Y; Ohnuma S; Tada S; Matsushima T; Hase K
    BMC Cancer; 2021 Dec; 21(1):1332. PubMed ID: 34906120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Prognosis and Recurrence Pattern of Right- and Left-Sided Colon Cancer in Stage II, Stage III, and Liver Metastasis After Curative Resection.
    Nakamura Y; Hokuto D; Koyama F; Matsuo Y; Nomi T; Yoshikawa T; Kamitani N; Sadamitsu T; Takei T; Matsumoto Y; Iwasa Y; Fukuoka K; Obara S; Nakamoto T; Kuge H; Sho M
    Ann Coloproctol; 2021 Oct; 37(5):326-336. PubMed ID: 32972100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
    Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microsatellite Status Affects Tumor Response and Survival in Patients Undergoing Neoadjuvant Chemotherapy for Clinical Stage III Gastric Cancer.
    Cai Z; Rui W; Li S; Fingerhut A; Sun J; Ma J; Zang L; Zhu Z; Zheng M
    Front Oncol; 2020; 10():614785. PubMed ID: 33384963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of high-risk features for stage II adenocarcinoma of the appendix.
    Akce M; Zakka K; Penley M; Jiang R; Khalil L; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF
    Cancer Treat Res Commun; 2021; 27():100329. PubMed ID: 33609973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.